previous compound ID: 340 next compound
InChIKey: CJCSPKMFHVPWAR-JTQLQIEISA-N
SMILES: C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"R Robert" "JW Hanrahan" "E Matthes" "J Liao" "GW Carlile" "B Kus" "SD Macknight" "D Rotin" "DY Thomas" "J Goepp"

chemical graph of compound 340





CID is 38853
synonyms found at PubChem are:
methyldopa, 555-30-6, Alphamethyldopa, Aldomet, Alpha medopa, Dopamet, l-alpha-Methyldopa, alpha-Methyl dopa, Baypresol, Hyperpax, Presolisin, Sedometil, Sembrina, Dopegyt, Medomet, Methyl dopa, Methyldopa anhydrous, Dopamethyperpax, Aldometil, Grospisk, Medopren, Methoplain, Presinol, Becanta, Dopatec, Hypolag, Medopa, Medopal, alpha-Methyldopa, Methyl-L-dopa, L-Methyl Dopa, Methyldopum, Aldomin, Dopegit, Metildopa, (S)-(-)-alpha-Methyldopa, 3-(3,4-DIHYDROXYPHENYL)-2-METHYL-L-ALANINE, L-(alpha-Md), 3-Hydroxy-alpha-methyl-L-tyrosine, alpha-Methyl-L-dopa, Bayer 1440 L, Apo-Methyldopa, L-alpha-Methyl DOPA, Nu-Medopa, alpha-Methyldopa (VAN), Dopergit, Novomedopa, alpha-Methyldihydroxyphenylalanine, alpha-Methyl-L-3,4-dihydroxyphenylalanine, L-alpha-Methyl-3,4-dihydroxyphenylalanine, L-Methyldopa, l-3-(3,4-Dihydroxyphenyl)-2-methylalanine, L-(-)-alpha-Methyldopa, Methyldopum [INN-Latin], Metildopa [INN-Spanish], Aldoril D30, Aldoril D50, Methyldopa (L,-), Methyldopa (anhydrous), levo-3-(3,4-Dihydroxyphenyl)-2-methylalanine, AMD, L-(-)-|A-Methyldopa, L-(-)-3-(3,4-Dihydroxyphenyl)-2-methylalanine, Nr.C 2294, alpha-Methyl-beta-(3,4-dihydroxyphenyl)-L-alanine, L(-)-beta-(3,4-Dihydroxyphenyl)-alpha-methylalanine, L-(-)-alpha-Methyl-beta-(3,4-dihydroxyphenyl)alanine, UNII-M4R0H12F6M, L-Tyrosine, 3-hydroxy-alpha-methyl-, MK 351, Methyldopa (INN), Methyldopa [INN], Aldomet (TN), Aldoril 15, Aldoril 25, L-2-Amino-2-methyl-3-(3,4-dihydroxyphenyl)propionic acid, (S)-2-Amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid, CCRIS 4671, HSDB 218, (2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid, CHEBI:61058, EINECS 209-089-2, Methyldopa (Levorotatory), NSC 169916, Mk. b51, 41372-08-1, MLS000028644, M4R0H12F6M, CJCSPKMFHVPWAR-JTQLQIEISA-N, 3-Hydroxy-.alpha.-methyl-L-tyrosine, MK-351, 88620-56-8, Alanine, 3-(3,4-dihydroxyphenyl)-2-methyl-, L-(-)-, NCI-C55721, SMR000059170, (-)-3-(3,4-Dihydroxyphenyl)-2-Methyl-L-Alanine Sesqui-Hydrate, Aldomine, Lederdopa, Q-201392, W-105555, METHYL DOPA (SEE ALSO METHYL DOPA SESQUIHYDRATE), SR-01000597712, aldochlor, Medoba, l-a-methyldopa, a-methyl dopa, NSC169916, a-methyl-l-dopa, 3,4-Dihydroxy-2-methylphenylalanine #, Anhydrous methyldopa, CAS-555-30-6, Prestwick_732, (-)-a-methyldopa, a-methyldopa (van), Aldoril (TN), Dopamet (TN), Dopegyt (TN), Methyldopa (Aldomet), Methyldopa 250 Tab, L-alpha-Methyl-DOPA, (-)-alpha-methyldopa, L-(-)--Methyldopa, L(-)-a-methylalanine, Spectrum_000937, Tocris-0584, MK-351; Methyldopa, Nu-Medopa Tab 125mg, Nu-Medopa Tab 250mg, Nu-Medopa Tab 500mg, L-(-)-?-Methyldopa, Novo-Medopa Tab 125mg, Novo-Medopa Tab 250mg, Novo-Medopa Tab 500mg, Prestwick0_000326, Prestwick1_000326, Prestwick2_000326, Prestwick3_000326, Spectrum2_001068, Spectrum3_000501, Spectrum4_000054, Spectrum5_001295, (s)-(-)-a-methyldopa, L(-)-alpha-methylalanine, DSSTox_CID_3295, CHEMBL459, D0BA6T, Epitope ID:146097, AC1Q29EL, AC1Q29EM, Apo Methyldopa Tab 125mg, Apo Methyldopa Tab 250mg, Apo Methyldopa Tab 500mg, DSSTox_RID_76962, DSSTox_GSID_23295, L-(a-MD), Lopac0_000853, SCHEMBL34003, BSPBio_000331, BSPBio_002021, KBioGR_000547, KBioSS_001417, cid_38853, MLS006011978, BIDD:GT0620, DivK1c_000142, Methyldopa 125 Tab 125mg, Methyldopa 500 Tab 500mg, SPECTRUM1500403, SPBio_001056, SPBio_002252, alpha-Methyl-dopa sesquihydrate, AC1L20K1, Aldoril;Dopamet;Dopegyt;Aldomet, BPBio1_000365, GTPL5217, DTXSID5023295, BDBM48449, CTK8B3998, HMS500H04, KBio1_000142, KBio2_001417, KBio2_003985, KBio2_006553, KBio3_001521, ZINC20255, MolPort-001-792-485, NINDS_000142, HMS1569A13, HMS1920N09, HMS2090B11, HMS2091F04, HMS2096A13, HMS2235N11, HMS3262L07, HMS3372J14, HMS3713A13, Pharmakon1600-01500403, L-(-)-a-methyl-a-methyl-Aldomin, HY-B0225, KS-00000VK2, Tox21_202610, Tox21_500853, ANW-43632, BG0252, CCG-40120, CM0081, DL-443, LS-216, NSC760080, s1642, Tyrosine, 3-hydroxy-.alpha.-methyl-, a-Methyl-L-3,4-dihydroxyphenylalanine, AKOS015960582, Aldoril, Dopamet, Dopegyt, Methyldopa, AC-8431, API0003115, CS-2172, DB00968, KS-1424, LP00853, MCULE-8885874119, NSC-760080, IDI1_000142, NCGC00024667-01, NCGC00024667-02, NCGC00024667-03, NCGC00024667-05, NCGC00024667-06, NCGC00024667-07, NCGC00024667-08, NCGC00024667-09, NCGC00024667-10, NCGC00024667-11, NCGC00024667-13, NCGC00260158-01, NCGC00261538-01, AC-11671, AJ-08427, AK114179, AS-13052, CC-30888, L-(-)-alpha-methyl-alpha-methyl-Aldomin, SC-21959, L-a-Methyl-(3, 4-dihydroxyphenyl)alanine, AB2000187, AX8021439, KB-211091, TR-019573, (-)-alpha-Methyl-3,4-dihydroxyphenylalanine, D1817, EU-0100853, FT-0603468, LT00847269, 3-(3,4-Dihydroxyphenyl)-?-methyl-L-alanine, L-alpha-Methyl-(3, 4-dihydroxyphenyl)alanine, C07194, D08205, AB00052043_09, AB01275508-01, AB01275508_02, C-10983, L-(-)-3-(3,4-dihydroxyphenyl)-2-methyl-Alanine, SR-01000597712-1, SR-01000597712-3, 3,4-dihydroxy-2-methylphenylalanine (ACD/Name 4.0), Z1565440340, 3-(3,4-Dihydroxyphenyl)-2-methyl-L-alanine sesquihydrate, Methyldopa, European Pharmacopoeia (EP) Reference Standard, UNII-33TD13T99R component CJCSPKMFHVPWAR-JTQLQIEISA-N, (2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid, Methyldopa, United States Pharmacopeia (USP) Reference Standard, Methyldopa for system suitability, European Pharmacopoeia (EP) Reference Standard, 133161-54-3, 1339-75-9, 4290-08-8, 779-08-8, L-(-)-AfAE'A centa' notA inverted exclamation markAfasA'A|AfAE'Adaggeratrade mark?-Methyldopa, AC1OCGED, ZB000781, (2S)-2-azaniumyl-3-(3,4-dihydroxyphenyl)-2-methylpropanoate